Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-26

Clinical Trial Update: HU007 in Patients with Dry Eye Syndrome [Phase 3]

View source ↗

Summary

Huons Co., Ltd. has completed a Phase 3 clinical trial evaluating HU007 for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HU007

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED